NCT04438681View on ClinicalTrials.gov

Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients

RecruitingOBSERVATIONAL

Enrollment

90

Participants

Timeline

Start Date

November 27, 2020

Primary Completion Date

November 9, 2026

Study Completion Date

November 9, 2029

Conditions

Triple Negative Breast Cancer

Trial Locations (1)

63011

RECRUITING

Centre Jean PERRIN, Clermont-Ferrand

All Listed Sponsors

lead

Centre Jean Perrin

OTHER